FDA "informal rulemaking" prohibition proposed by House Budget Cmte..
This article was originally published in The Tan Sheet
Executive Summary
FDA "INFORMAL RULEMAKING" PROHIBITION PROPOSED BY HOUSE BUDGET CMTE. in its report on the fiscal year 1996 budget resolution. "The FDA currently makes policy through a variety of improper means," such as "points to consider" documents, draft guidances, speeches and warning letters, according to the report. These activities, which "are difficult to track yet often contain substantive rules," should be eliminated by withholding funding for them through the appropriations process, the committee report states.